Businessman and philanthropist Andrew Barnes is donating £10 million to the University to establish the Charlotte Lockhart Precision Breast Cancer Institute, named after his beloved partner, who has terminal breast cancer.
Scientists have found the strongest evidence to date that a condition known as Barrett’s oesophagus is the starting point for all cases of oesophageal adenocarcinoma – the most common type of oesophageal cancer in the developed world – even when telltale signs of this pre-cancerous stage are no longer visible.
Complex digital images of tissue samples that can take an experienced pathologist up to 20 minutes to annotate could be analysed in just one minute using a new AI tool developed by researchers at the University of Cambridge.
NHS patients at Addenbrooke’s Hospital, Cambridge, will become the first in the UK and Europe to undergo incisionless ultrasound surgery using a cutting-edge ‘histotripsy machine’ as part of their cancer care.
Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ovarian cancer. Now, Cambridge researchers have shown that this procedure – known as bilateral salpingo-oophorectomy (BSO) – is associated with a substantial reduction in the risk of early death among these women, without any serious side-effects.
The Secretary of State for Health and Social Care has announced that ambitious plans can proceed for Cambridge Cancer Research Hospital, which promises to change the story of cancer forever.
A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.
New, repurposed and combined treatments could soon transform prostate cancer outcomes, with DNA repair research informing promising clinical trials at Cambridge.
Find out about groundbreaking cancer research at Cambridge, including our planned new hospital, how we're studying the earliest stages of cancer, how AI is helping fight the disease, and the patients playing a key role in our work.
Researchers and clinicians are now welcoming new perspectives: those of people with experience of cancer.
© 2026 University of Cambridge